These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 3755908

  • 1. Muscarinic receptor subtypes in bovine adrenal medulla.
    Yamanaka K, Kigoshi S, Muramatsu I.
    Biochem Pharmacol; 1986 Sep 15; 35(18):3151-7. PubMed ID: 3755908
    [Abstract] [Full Text] [Related]

  • 2. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE.
    Mol Pharmacol; 1986 Jul 15; 30(1):58-68. PubMed ID: 3755217
    [Abstract] [Full Text] [Related]

  • 3. Tetranitromethane modification of the muscarinic receptors in bovine adrenal medulla.
    Yamanaka K, Muramatsu I, Kigoshi S.
    Jpn J Pharmacol; 1988 Sep 15; 48(1):67-76. PubMed ID: 3199607
    [Abstract] [Full Text] [Related]

  • 4. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
    Luthin GR, Wolfe BB.
    J Pharmacol Exp Ther; 1984 Mar 15; 228(3):648-55. PubMed ID: 6546770
    [Abstract] [Full Text] [Related]

  • 5. Species difference in the muscarinic receptors of thoracic aorta.
    Yamanaka K, Hashimoto S, Muramatsu I.
    J Pharmacol Exp Ther; 1986 Jun 15; 237(3):980-6. PubMed ID: 3754896
    [Abstract] [Full Text] [Related]

  • 6. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
    Luthin GR, Wolfe BB.
    J Pharmacol Exp Ther; 1985 Jul 15; 234(1):37-44. PubMed ID: 3839265
    [Abstract] [Full Text] [Related]

  • 7. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M, Roeske WR, Yamamura HI.
    J Pharmacol Exp Ther; 1986 May 15; 237(2):419-27. PubMed ID: 3754581
    [Abstract] [Full Text] [Related]

  • 8. Different agonist binding properties of M1 and M2 muscarinic receptors in calf brain cortex membranes.
    Vanderheyden P, Ebinger G, Vauquelin G.
    Biochem Pharmacol; 1987 Dec 01; 36(23):4119-24. PubMed ID: 3689439
    [Abstract] [Full Text] [Related]

  • 9. Characterization of cholinergic muscarinic receptors in the rabbit iris.
    Honkanen RE, Abdel-Latif AA.
    Biochem Pharmacol; 1988 Jul 01; 37(13):2575-83. PubMed ID: 3291881
    [Abstract] [Full Text] [Related]

  • 10. Biochemical characteristics of muscarinic cholinoreceptors in swine tracheal smooth muscle.
    Yang CM, Farley JM, Dwyer TM.
    J Auton Pharmacol; 1986 Mar 01; 6(1):15-24. PubMed ID: 3957950
    [Abstract] [Full Text] [Related]

  • 11. High-affinity [3H]pirenzepine binding to putative M1 muscarinic sites in the neuroblastoma x glioma hybrid cell line (NG 108-15).
    Akiyama K, Watson M, Roeske WR, Yamamura HI.
    Biochem Biophys Res Commun; 1984 Feb 29; 119(1):289-97. PubMed ID: 6546688
    [Abstract] [Full Text] [Related]

  • 12. Selectivity of oxomemazine for the M1 muscarinic receptors.
    Lee SW, Woo CW, Kim JG.
    Arch Pharm Res; 1994 Dec 29; 17(6):443-51. PubMed ID: 10319156
    [Abstract] [Full Text] [Related]

  • 13. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
    Ehlert FJ, Jenden DJ.
    Mol Pharmacol; 1985 Aug 29; 28(2):107-19. PubMed ID: 3839562
    [Abstract] [Full Text] [Related]

  • 14. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
    Watson M, Yamamura HI, Roeske WR.
    J Pharmacol Exp Ther; 1986 May 29; 237(2):411-8. PubMed ID: 3754580
    [Abstract] [Full Text] [Related]

  • 15. Muscarinic cholinergic receptors in canine adrenal gland.
    Tobin JR, Breslow MJ, Traystman RJ.
    Am J Physiol; 1992 Oct 29; 263(4 Pt 2):H1208-12. PubMed ID: 1415769
    [Abstract] [Full Text] [Related]

  • 16. Ligand binding and G protein coupling of muscarinic receptors in airway smooth muscle.
    Lucchesi PA, Scheid CR, Romano FD, Kargacin ME, Mullikin-Kilpatrick D, Yamaguchi H, Honeyman TW.
    Am J Physiol; 1990 Apr 29; 258(4 Pt 1):C730-8. PubMed ID: 2110418
    [Abstract] [Full Text] [Related]

  • 17. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
    Dunlap J, Brown JH.
    Mol Pharmacol; 1983 Jul 29; 24(1):15-22. PubMed ID: 6135150
    [Abstract] [Full Text] [Related]

  • 18. Copper-induced alteration of muscarinic binding in bovine adrenal medulla.
    Yamanaka K, Kigoshi S, Muramatsu I.
    Jpn J Pharmacol; 1986 Jul 29; 41(3):415-8. PubMed ID: 3761756
    [Abstract] [Full Text] [Related]

  • 19. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
    Norman AB, Creese I.
    Mol Pharmacol; 1986 Aug 29; 30(2):96-103. PubMed ID: 3755499
    [Abstract] [Full Text] [Related]

  • 20. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
    Lee NH, el-Fakahany EE.
    J Pharmacol Exp Ther; 1988 Sep 29; 246(3):829-38. PubMed ID: 3418516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.